VRTX
UNDERPERFORMVertex Pharmaceuticals Incorporated · Healthcare
$440.99-1.30%LAST CLOSE
24H-1.30%
1W+0.52%
1M-10.44%
1Y-6.64%
Live Chart · VRTX
1DNY TIME
BOGA Master Score
29.9
High conviction score
BOGA AI Model Projection
Strategic Observation Zone$438.79 - $443.19
Projected Growth Objective$466.80 - $500.15
Model Invalidation Level$396.56 - $417.43
Risk/Reward1.5:1
AD-S2 · 300×250 Sidebar
Technical Indicators
RSI (14)
43.7
Neutral
MACD
-0.003
NEUTRAL
RVOL
0.65x
Normal
Trends
UP
UP
EMA Stack
Bearish
STABLE
BB Squeeze
MEDIUM
MONITOR
Fundamentals & Margins
Market Cap
P/E Ratio
vs Sector: 25.0730915
FCF Yield
Gross Margin
Operating Margin
Net Margin
Sector Context
Benchmarked against
XLV
5D Performance
+1.3%
VRTX is currently ranked in the top 20% of its sector based on BOGA Master Scores. It has outperformed XLV by 4.2% over the last 30 trading days.
Insider Activity (90D)
| Transaction | Shares | Net Direction |
|---|---|---|
| Buys | 0 | SELL |
| Sells | 30 |
Last Transaction: SELL 978 shares

Share This Insight
Help others discover this score. Professional analysts share high-conviction data.
Share This Insight
Help others discover this score. Professional analysts share high-conviction data.